reports
- GlobalData Healthcare Department
Strongbridge Biopharma plc (SBBP) - Financial Analysis Review
Summary Strongbridge Biopharma plc (SBBP) - Financial Analysis Review Summary Strongbridge Biopharma plc (Strongbridge), formerly Cortendo plc, is a commercial-stage biopharmaceutical company that develops and commercializes therapies for rare diseases. The company’s marketed product, KEVEYIS (dichlorphenamide), is indicated for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis, a genetic neuromuscular disorder. GlobalData's Strongbridge Biophar...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.